Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Personalized Cancer Vaccines Go Viral: Viral Vectors in the Era of Personalized Immunotherapy of Cancer
Laura Seclì, Guido Leoni, Valentino Ruzza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16591-16591
Open Access | Times Cited: 15

Showing 15 citing articles:

Advancing personalized immunotherapy for melanoma: Integrating immunoinformatics in multi-epitope vaccine development, neoantigen identification via NGS, and immune simulation evaluation
Mohammad Javad Kamali, Mohammad Salehi, Mohsen Karami Fath
Computers in Biology and Medicine (2025) Vol. 188, pp. 109885-109885
Closed Access | Times Cited: 2
The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap
Anneliene Hechtelt Jonker, Elena-Alexandra Tãtaru, Holm Graeßner, et al.
Nature Reviews Drug Discovery (2024) Vol. 24, Iss. 1, pp. 40-56
Closed Access | Times Cited: 5
Hybrid lipid nanoparticles with tumor antigen-primed dendritic cell membranes for post-surgical tumor immunotherapy
Dongyoon Kim, Jiwon Choi, D-H Jin, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 537-548
Closed Access
Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy
Violeta Delgado-Almenta, José L. Blaya-Cánovas, Jesús Calahorra, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 216-216
Open Access
Identification of new immune target and signaling for cancer immunotherapy
S. P. Narote, Sharav Desai, Vipul P. Patel, et al.
Cancer Genetics (2025)
Closed Access
Advances in cancer nanovaccines: a focus on colorectal cancer
Yalda Ghazizadeh, Hossein Salehi Shadkami, Fatemeh Madani, et al.
Nanomedicine (2025), pp. 1-13
Closed Access
Neoantigen vaccines: advancing personalized cancer immunotherapy
Alaa A. A. Aljabali, Yassmen Hamzat, Alaa Alqudah, et al.
Exploration of Immunology (2025) Vol. 5
Open Access
Adenovirus-based strategies for cancer vaccines
Kexin Geng, William E. Gillanders
Elsevier eBooks (2025), pp. 545-572
Closed Access
Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials
Iman Karimi-Sani, Zahra Molavi, Samaneh Naderi, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges
Marco Palma
Vaccines (2025) Vol. 13, Iss. 4, pp. 344-344
Open Access
Unlocking cancer vaccine potential: What are the key factors?
Michael Grant, Lian Ni Lee, Senthil Chinnakannan, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Advances in Therapeutic Cancer Vaccines, Their Obstacles, and Prospects Toward Tumor Immunotherapy
Azadeh Eskandari, Thean Chor Leow, Mohd Basyaruddin Abdul Rahman, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3
Lung cancer vaccination from concept to reality: A critical review of clinical trials and latest advances
Mohammad‐Javad Sanaei, Atieh Pourbagheri‐Sigaroodi, Alireza Rezvani, et al.
Life Sciences (2024) Vol. 346, pp. 122652-122652
Closed Access | Times Cited: 2
The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems
Nargish Parvin, Tapas Kumar Mandal, Sang‐Woo Joo
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1366-1366
Open Access | Times Cited: 1
Molecular and modular intricacies of precision oncology
Ravneet Chhabra
Frontiers in Immunology (2024) Vol. 15
Open Access
Targeting immunometabolism to improve cancer therapies
Darby J. Ballard, Liqing Wang, Jugal Kishore Das, et al.
Elsevier eBooks (2024), pp. 95-116
Closed Access
Immunoadjuvants in Cancer Immunotherapy
Mamta N. Talati, Neeraj Kumar Chouhan, Mani Sharma, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 311-350
Closed Access
Page 1

Scroll to top